Replies to post #51087 on $heff's $tation of $tocks & $olid DD

[$heff]

BPAX .54 (NASD) Chart on watch as bottomplay. PDUFA of Feb 14th for Bio-T-Gel. Large short position. Trader's stock that is very volatile. 52wk Range: .38 - 4.02

[Investor100]

OT: FDA Panel Calendar

Stocks that have PDUFA decisions in March and one key stock with advisory committee meeting!

Date:02/26/2012
Company:Columbia Laboratories, Inc.
Ticker:CBRX
Drug:PROCHIEVE
Event:PDUFA 2/26/12 of PROCHIEVE for reduction of risk of preterm birth.

Date:03/06/2012
Company:Astex Pharmaceuticals, Inc.
Ticker:ASTX
Drug:Dacogen
Event:PDUFA 3/6/12 of sNDA of Dacogen for Acute myeloid leukemia (AML)


Date:03/06/2012
Company:Discovery Laboratories, Inc.
Ticker:DSCO
Drug:Surfaxin
Event:PDUFA 3/6/12 of Surfaxin for Respiratory Distress Syndrome


Date: 03/07/2012
Company:NeurogesX, Inc.
Ticker:NGSX
Drug:Qutenza
Event:PDUFA 3/7/12 of Qutenza for Neuropathic pain associated with HIV-associated peripheral neuropathy (HIV-PN)


Date:03/21/2012
Company:TALON THERAPEUTICS
Ticker:TLON
Drug:Marqibo
Event:Advisory Committee Meeting March 21, 2012 for Marqibo in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia

Date:03/26/2012
Company:MAP Pharmaceuticals, Inc.
Ticker:MAPP
Drug:Levadex
Event:PDUFA 3/26/12 of LEVADEX for Migraine


Date:03/27/2012
Company:Affymax, Inc.
Ticker:AFFY
Drug:Peginestide
Event:PDUFA 3/27/2012 of Peginesatide for Anemia in chronic renal failure (CRF)

Date:03/28/2012
Company:Chelsea Therapeutics Internatio
Ticker:CHTP
Drug:Northera
Event:PDUFA 3/28/2012 of Northera for Neurogenic Orthostatic Hypotension

Investor 100